EX-23.1 23 d772541dex231.htm CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM <![CDATA[Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm]]>

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 12, 2014, in the Registration Statement (Form S-1) and related Prospectus of Juno Therapeutics, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Seattle, Washington

November 14, 2014